Cartesian Therapeutics Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

RNAC
Cartesian Therapeutics

Last Price:

$10.41

Seasonality Move:

13.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed investing in Uber? Don't Miss Mode.

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Cartesian Therapeutics Stock Forecast

Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 11.1% based on the past 8 years of stock performance.
Cartesian Therapeutics has fallen lower in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Cartesian Therapeutics Stock Undervalued?

The current Cartesian Therapeutics [RNAC] share price is $9.90. The Score for RNAC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
RNAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Cartesian Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 11.1% based on the past 8 years of stock performance.

Cartesian Therapeutics Stock Rating

Sell

Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics overpriced?

Cartesian Therapeutics has fallen lower in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Cartesian Therapeutics Stock Price History

Is RNAC stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

cartesiantherapeutics.com

52-Week Data

52-Week High:

41.87

52-Week Low:

8.85

Prediction Charts

Market Cap:

256.8M

Price in USD:

9.90

Volume:

215.9K

Beta:

0.91

Technical Analysis

SMA50:

13.54

SMA100:

16.15

SMA200:

17.02

52-Wk Change:

-54.71%

Stock Predictions

Is Cartesian Therapeutics stock public?

Yes, Cartesian Therapeutics is a publicly traded company.
What is the Cartesian Therapeutics stock quote today?

The Cartesian Therapeutics stock price is 9.90 USD today.
How to buy Cartesian Therapeutics stock online?

You can buy Cartesian Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	10.45	11.26	11.41	10.45
Apr-23	11.62	11.63	11.97	11.32
Apr-24	11.63	12.05	12.18	11.63
Apr-25	11.87	11.83	12.05	11.51
Apr-28	11.96	12.21	12.40	11.63
Apr-29	12.21	11.90	12.40	11.81
Apr-30	11.62	12.00	12.20	11.18
May-1	12.02	12.27	12.45	11.56
May-2	12.20	12.70	12.95	12.00
May-5	12.68	12.44	13.10	12.43
May-6	12.28	10.57	12.49	10.49
May-7	10.67	10.15	10.80	10.03
May-8	10.26	10.42	11.31	10.00
May-9	10.38	9.90	10.53	9.51

Cartesian Therapeutics Earnings

Cartesian Therapeutics Earnings Report: Per Share Cartesian Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cartesian Therapeutics Forecast Revenue Growth

Cartesian Therapeutics Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $1.95 per share.

* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.